stage iia breast cancer ajcc v6 and v7
Showing 1 - 25 of 30
HER2/Neu Positive, Progesterone Receptor Positive, Recurrent Breast Carcinoma Trial in Worldwide (drug, other, biological)
Active, not recruiting
- HER2/Neu Positive
- +8 more
- Cyclophosphamide
- +7 more
-
Anniston, Alabama
- +1291 more
Jan 28, 2023
Breast Adenocarcinoma, Hormone Receptor Positive, Stage IA Breast Cancer AJCC v7 Trial in Worldwide (drug, other, radiation)
Active, not recruiting
- Breast Adenocarcinoma
- +6 more
- Anastrozole
- +6 more
-
Anniston, Alabama
- +1230 more
Jan 28, 2023
Male Breast Carcinoma, Stage IIA Breast Cancer AJCC v6 and v7, Stage IIB Breast Cancer AJCC v6 and v7 Trial in United States
Active, not recruiting
- Male Breast Carcinoma
- +4 more
- Bevacizumab
- +5 more
-
Jonesboro, Arkansas
- +452 more
Jan 13, 2023
Bilateral Breast Carcinoma, Breast Inflammatory Carcinoma, Stage IB Breast Cancer AJCC v7 Trial in United States (drug, other,
Active, not recruiting
- Bilateral Breast Carcinoma
- +11 more
- Cyclophosphamide
- +4 more
-
Scottsdale, Arizona
- +11 more
Jan 12, 2023
HER2-positive Breast Cancer, Breast Adenocarcinoma, Stage II Breast Cancer AJCC v6 and v7 Trial in San Francisco (Neratinib,
Completed
- HER2-positive Breast Cancer
- +8 more
- Neratinib
- +3 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jan 6, 2023
Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7, Stage IB Breast Cancer AJCC v7 Trial in Scottsdale, Jacksonville,
Active, not recruiting
- Stage I Breast Cancer AJCC v7
- +6 more
- Hypofractionated Radiation Therapy
- +2 more
-
Scottsdale, Arizona
- +2 more
Jan 3, 2023
Stage 0 Breast Cancer AJCC v6 and v7, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7 Trial in United States
Recruiting
- Stage 0 Breast Cancer AJCC v6 and v7
- +10 more
- Telemedicine
- +6 more
-
Washington Township, New Jersey
- +4 more
Oct 18, 2022
Peripheral Neuropathy, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7 Trial in Columbus (Educational
Completed
- Peripheral Neuropathy
- +6 more
- Educational Intervention
- +4 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Oct 10, 2022
Stage II Breast Cancer AJCC v6 and v7, Stage IIA Breast Cancer AJCC v6 and v7, Stage IIB Breast Cancer AJCC v6 and v7 Trial in
Active, not recruiting
- Stage II Breast Cancer AJCC v6 and v7
- +6 more
- Behavioral, Psychological or Informational Intervention
- +8 more
-
Houston, TexasM D Anderson Cancer Center
Oct 6, 2022
Breast Adenocarcinoma, Stage II Breast Cancer AJCC v6 and v7, Stage IIA Breast Cancer AJCC v6 and v7 Trial in United States
Recruiting
- Breast Adenocarcinoma
- +7 more
- Multi-epitope HER2 Peptide Vaccine TPIV100
- +5 more
-
Scottsdale, Arizona
- +26 more
Aug 17, 2022
Invasive Breast Carcinoma, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7 Trial in United States
Recruiting
- Invasive Breast Carcinoma
- +8 more
- Hypofractionated Radiation Therapy
- +4 more
-
Gilbert, Arizona
- +8 more
Jun 23, 2022
Invasive Breast Carcinoma, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7 Trial in Detroit (Laboratory Biomarker
Active, not recruiting
- Invasive Breast Carcinoma
- +6 more
- Laboratory Biomarker Analysis
- Simvastatin
-
Detroit, MichiganWayne State University/Karmanos Cancer Institute
Jun 17, 2022
Invasive Breast Carcinoma, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7 Trial in United States (drug, other,
Recruiting
- Invasive Breast Carcinoma
- +11 more
- Chemotherapy
- +4 more
-
Conroe, Texas
- +4 more
May 3, 2022
Positive Axillary Lymph Node, Stage 0 Breast Cancer AJCC v6 and v7, Stage I Breast Cancer AJCC v7 Trial in Los Angeles
Completed
- Positive Axillary Lymph Node
- +11 more
- Implanted Medical Device
- Therapeutic Conventional Surgery
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Mar 29, 2022
Cancer Survivor, Stage I Breast Cancer AJCC v7, Stage I Colon Cancer AJCC v6 and v7 Trial in Scottsdale (American Ginseng,
Completed
- Cancer Survivor
- +19 more
- American Ginseng
- +3 more
-
Scottsdale, ArizonaMayo Clinic in Arizona
Mar 22, 2022
Invasive Breast Carcinoma, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7 Trial in Houston (procedure, drug,
Recruiting
- Invasive Breast Carcinoma
- +11 more
- Axillary Lymph Node Dissection
- +5 more
-
Houston, Texas
- +1 more
Mar 10, 2022
Breast Ductal Carcinoma In Situ, Breast Lobular Carcinoma In Situ, Stage 0 Breast Cancer AJCC v6 and v7 Trial in Los Angeles,
Active, not recruiting
- Breast Ductal Carcinoma In Situ
- +12 more
- Endoxifen Hydrochloride
- +2 more
-
Los Angeles, California
- +2 more
Mar 8, 2022
Male Breast Carcinoma, Stage IIA Breast Cancer AJCC v6 and v7, Stage IIB Breast Cancer AJCC v6 and v7 Trial in Puerto Rico,
Active, not recruiting
- Male Breast Carcinoma
- +5 more
- Laboratory Biomarker Analysis
- +3 more
-
Tucson, Arizona
- +317 more
Mar 1, 2022
Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7, Stage IB Breast Cancer AJCC v7 Trial in Houston (Carboplatin,
Recruiting
- Stage I Breast Cancer AJCC v7
- +10 more
- Carboplatin
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jan 12, 2022
Breast Adenocarcinoma, Ductal Breast Carcinoma In Situ, Invasive Breast Carcinoma Trial in Houston (Accelerated Partial Breast
Recruiting
- Breast Adenocarcinoma
- +9 more
- Accelerated Partial Breast Irradiation
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Dec 21, 2021
Stage 0 Breast Cancer AJCC v6 and v7, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7 Trial in Italy, United
Active, not recruiting
- Stage 0 Breast Cancer AJCC v6 and v7
- +6 more
- Exemestane
- +6 more
-
Tampa, Florida
- +4 more
Dec 15, 2021
Ductal Breast Carcinoma In Situ, Invasive Breast Carcinoma, Stage I Breast Cancer AJCC v6 Trial in United States (External Beam
Active, not recruiting
- Ductal Breast Carcinoma In Situ
- +7 more
- External Beam Radiation Therapy
- +5 more
-
Gilbert, Arizona
- +6 more
Oct 21, 2021
Ductal Breast Carcinoma In Situ, Early-Stage Breast Carcinoma, Invasive Breast Carcinoma Trial in United States (Laboratory
Recruiting
- Ductal Breast Carcinoma In Situ
- +9 more
- Laboratory Biomarker Analysis
- +2 more
-
Jacksonville, Florida
- +15 more
Oct 12, 2021
HER2-Positive Breast Carcinoma, Hormone Receptor-Positive Breast Carcinoma, Stage IB Breast Cancer AJCC v7 Trial in Puerto Rico,
Active, not recruiting
- HER2-Positive Breast Carcinoma
- +7 more
- Aromatase Inhibition Therapy
- +10 more
-
Fairbanks, Alaska
- +736 more
Oct 8, 2021
HER2 Positive Breast Carcinoma, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7 Trial in Norfolk, Omaha (drug,
Active, not recruiting
- HER2 Positive Breast Carcinoma
- +6 more
- Cyclophosphamide
- +3 more
-
Norfolk, Nebraska
- +2 more
Sep 1, 2021